Role of Oral Microbiota in Cancer Development

Microorganisms - Tập 7 Số 1 - Trang 20
Tomasz M. Karpiński1
1Department of Medical Microbiology, Poznań University of Medical Sciences, Wieniawskiego 3, 61-712 Poznań, Poland

Tóm tắt

Nowadays cancer is the second main cause of death in the world. The most known bacterial carcinogen is Helicobacter pylori. Pathogens that can have an impact on cancer development in the gastrointestinal tract are also found in the oral cavity. Some specific species have been identified that correlate strongly with oral cancer, such as Streptococcus sp., Peptostreptococcus sp., Prevotella sp., Fusobacterium sp., Porphyromonas gingivalis, and Capnocytophaga gingivalis. Many works have also shown that the oral periopathogens Fusobacterium nucleatum and Porphyromonas gingivalis play an important role in the development of colorectal and pancreatic cancer. Three mechanisms of action have been suggested in regard to the role of oral microbiota in the pathogenesis of cancer. The first is bacterial stimulation of chronic inflammation. Inflammatory mediators produced in this process cause or facilitate cell proliferation, mutagenesis, oncogene activation, and angiogenesis. The second mechanism attributed to bacteria that may influence the pathogenesis of cancers by affecting cell proliferation is the activation of NF-κB and inhibition of cellular apoptosis. In the third mechanism, bacteria produce some substances that act in a carcinogenic manner. This review presents potentially oncogenic oral bacteria and possible mechanisms of their action on the carcinogenesis of human cells.

Từ khóa


Tài liệu tham khảo

(2018, December 05). Cancer. Available online: https://www.who.int/cancer/en/ World Health Organization.

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 68, 394, 10.3322/caac.21492

(2018, December 05). Oral Cancer. Available online: https://www.who.int/cancer/prevention/diagnosis-screening/oral-cancer/en/ World Health Organization.

Montero, 2015, Cancer of the oral cavity, Surg. Oncol. Clin. N. Am., 24, 491, 10.1016/j.soc.2015.03.006

International Agency for Research on Cancer (1994). Schistosomes, Liver Flukes and Helicobacter pylori. Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer. IARC Monograph Evaluating Carcinogenic Risks to Humans.

Andrzejewska, 2015, Evaluation of antimicrobial resistance of Helicobacter pylori in the last 15 years in West Poland, Acta Microbiol. Immunol. Hung., 62, 287, 10.1556/030.62.2015.3.6

Sasaki, 2005, Streptococcus anginosus infection in oral cancer and its infection route, Oral Dis., 11, 151, 10.1111/j.1601-0825.2005.01051.x

Mager, 2005, The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, nonrandomized study of cancer-free and oral squamous cell carcinoma subjects, J. Transl. Med., 3, 27, 10.1186/1479-5876-3-27

Katz, 2011, Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma, Int. J. Oral Sci., 3, 209, 10.4248/IJOS11075

Pushalkar, S., Ji, X., Li, Y., Estilo, C., Yegnanarayana, R., Singh, B., Li, X., and Saxena, D. (2012). Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma. BMC Microbiol., 12.

Atanasova, 2014, Looking in the Porphyromonas gingivalis cabinet of curiosities: The microbium, the host and cancer association, Mol. Oral Microbiol., 29, 55, 10.1111/omi.12047

2016, Oral microbiome, periodontitis and risk of head and neck cancer, Oral Oncol., 53, 17, 10.1016/j.oraloncology.2015.11.013

Lee, 2017, Bacterial alterations in salivary microbiota and their association in oral cancer, Sci. Rep., 7, 16540, 10.1038/s41598-017-16418-x

Nagy, 1998, The microflora associated with human oral carcinomas, Oral Oncol., 34, 304, 10.1016/S1368-8375(98)80012-2

Castellarin, 2012, Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma, Genome Res., 22, 299, 10.1101/gr.126516.111

Ahn, 2013, Human gut microbiome and risk for colorectal cancer, J. Natl. Cancer Inst., 105, 1907, 10.1093/jnci/djt300

Kostic, 2013, Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment, Cell Host Microbe, 14, 207, 10.1016/j.chom.2013.07.007

Michaud, 2013, Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study, Gut, 62, 1764, 10.1136/gutjnl-2012-303006

Flanagan, 2014, Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome, Eur. J. Clin. Microbiol. Infect. Dis., 33, 1381, 10.1007/s10096-014-2081-3

Mitsuhashi, 2015, Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis, Oncotarget, 6, 7209, 10.18632/oncotarget.3109

Fan, 2018, Human oral microbiome and prospective risk for pancreatic cancer: A population-based nested case-control study, Gut, 67, 120, 10.1136/gutjnl-2016-312580

Shiga, 2001, Presence of Streptococcus infection in extra-oropharyngeal head and neck squamous cell carcinoma and its implication in carcinogenesis, Oncol Rep., 8, 245

Narikiyo, 2004, Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers, Cancer Sci., 95, 569, 10.1111/j.1349-7006.2004.tb02488.x

Sakamoto, 1999, Isolation of bacteria from cervical lymph nodes in patients with oral cancer, Arch. Oral Biol., 44, 789, 10.1016/S0003-9969(99)00079-5

Kostic, 2012, Genomic analysis identifies association of Fusobacterium with colorectal carcinoma, Genome Res., 22, 292, 10.1101/gr.126573.111

Tahara, 2014, Fusobacterium in colonic flora and molecular features of colorectal carcinoma, Cancer Res., 74, 1311, 10.1158/0008-5472.CAN-13-1865

Mima, 2016, Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location, Clin. Transl. Gastroenterol., 7, e200, 10.1038/ctg.2016.53

Farrell, 2012, Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer, Gut, 61, 582, 10.1136/gutjnl-2011-300784

Yan, 2015, Discovery and validation of potential bacterial biomarkers for lung cancer, Am. J. Cancer Res., 5, 3111

Jedlicka, 2016, 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment, Oncotarget, 7, 51320, 10.18632/oncotarget.9710

Ahn, 2012, Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality, Carcinogenesis, 33, 1055, 10.1093/carcin/bgs112

Peters, 2017, Oral microbiome composition reflects prospective risk for esophageal cancers, Cancer Res., 77, 6777, 10.1158/0008-5472.CAN-17-1296

Gao, 2015, Microbiota disbiosis is associated with colorectal cancer, Front. Microbiol., 6, 20, 10.3389/fmicb.2015.00020

Zhang, 2018, Human oral microbiota and its modulation for oral health, Biomed. Pharmacother., 99, 883, 10.1016/j.biopha.2018.01.146

Szkaradkiewicz, 2013, Microbiology of chronic periodontitis, J. Biol. Earth Sci., 3, M14

Hou, 2003, Interleukin-1β, clinical parameters and matched cellular-histopathologic changes of biopsied gingival tissue from periodontitis patients, J. Period. Res., 38, 247, 10.1034/j.1600-0765.2003.02601.x

Konopka, 2010, Cytokines in gingival crevicular fluid as potential diagnostic and prognostic markers of periodontitis, Dent. Med. Probl., 47, 206

Carmi, 2013, The role of IL-1β in the early tumor cell-induced angiogenic response, J. Immunol., 190, 3500, 10.4049/jimmunol.1202769

Jin, 1997, Expression of interleukin-1beta in human breast carcinoma, Cancer, 80, 421, 10.1002/(SICI)1097-0142(19970801)80:3<421::AID-CNCR10>3.0.CO;2-Z

Voronov, 2003, IL-1 is required for tumor invasiveness and angiogenesis, Proc. Natl. Acad. Sci. USA, 100, 2645, 10.1073/pnas.0437939100

Wang, 2005, SHP-2 promoting migration and metastasis of MCF-7 with loss of E-cadherin, dephosphorylation of FAK and secretion of MMP-9 induced by IL-1beta in vivo and in vitro, Breast Cancer Res. Treat., 89, 5, 10.1007/s10549-004-1002-z

Pannone, 2014, The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage, Curr. Cancer Drug Targets, 14, 115, 10.2174/1568009613666131126115012

Wong, 2018, E-cadherin: Its dysregulation in carcinogenesis and clinical implications, Crit. Rev. Oncol. Hematol., 121, 11, 10.1016/j.critrevonc.2017.11.010

Ishimi, 1990, IL-6 is produced by osteoblasts and induces bone resorption, J. Immunol., 145, 3297, 10.4049/jimmunol.145.10.3297

Gabay, 2006, Interleukin-6 and chronic inflammation, Arthritis Res. Ther., 8, S3, 10.1186/ar1917

Hogge, 2008, Interleukin-1beta and interleukin-6 disturb the antioxidant enzyme system in bovine chondrocytes: A possible explanation for oxidative stress generation, Osteoarthr.Cartil., 16, 756, 10.1016/j.joca.2007.10.009

Murata, 2012, Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis, J. Biomed. Biotechnol., 2012, 623019, 10.1155/2012/623019

Kossakowska, 1999, Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin’s lymphomas, Blood, 94, 2080, 10.1182/blood.V94.6.2080

Natali, 1990, Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions, Cancer Res., 50, 1271

Haura, 2005, Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer, Nat. Rev. Clin. Oncol., 2, 315, 10.1038/ncponc0195

Bradley, 2008, TNF-mediated inflammatory disease, J. Pathol., 214, 149, 10.1002/path.2287

Serdar, 2005, Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-α in patients with chronic and aggressive periodontitis, J. Periodontol., 76, 1849, 10.1902/jop.2005.76.11.1849

Szlosarek, 2006, Tumour necrosis factor-alpha as a tumour promoter, Eur. J. Cancer, 42, 745, 10.1016/j.ejca.2006.01.012

Rivas, 2008, TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways, Exp. Cell Res., 314, 509, 10.1016/j.yexcr.2007.10.005

Yan, 2006, Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation, Cancer Res., 66, 11565, 10.1158/0008-5472.CAN-06-2540

Leber, 1998, Regulation of monocyte MMP-9 production by TNF-alpha and a tumour-derived soluble factor (MMPSF), Br. J. Cancer, 78, 724, 10.1038/bjc.1998.568

Yoshida, 1997, Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis, Mol. Cell Biol., 17, 4015, 10.1128/MCB.17.7.4015

Gholizadeh, 2016, Role of oral microbiome on oral cancers, a review, Biomed. Pharmacother., 84, 552, 10.1016/j.biopha.2016.09.082

Yilmaz, 2004, Activation of the phosphatidylinositol 3-kinase/Akt pathway contributes to survival of primary epithelial cells infected with the periodontal pathogen Porphyromonas gingivalis, Infect. Immun., 72, 3743, 10.1128/IAI.72.7.3743-3751.2004

Mao, 2007, Intrinsic apoptotic pathways of gingival epithelial cells modulated by Porphyromonas gingivalis, Cell. Microbiol., 9, 1997, 10.1111/j.1462-5822.2007.00931.x

Whitmore, S.E., and Lamont, R.J. (2014). Oral bacteria and cancer. PLoS Pathog., 10.

Yao, 2010, Porphyromonas gingivalis infection sequesters pro-apoptotic Bad through Akt in primary gingival epithelial cells, Mol. Oral Microbiol., 25, 89, 10.1111/j.2041-1014.2010.00569.x

Nakhjiri, 2001, Inhibition of epithelial cell apoptosis by Porphyromonas gingivalis, FEMS Microbiol. Lett., 200, 145, 10.1111/j.1574-6968.2001.tb10706.x

Yilmaz, 2008, ATP scavenging by the intracellular pathogen Porphyromonas gingivalis inhibits P2X7-mediated host-cell apoptosis, Cell Microbiol., 10, 863, 10.1111/j.1462-5822.2007.01089.x

Choi, 2013, Porphyromonas gingivalis-nucleoside-diphosphate-kinase inhibits ATP-induced reactive-oxygen-species via P2X7 receptor/NADPH-oxidase signalling and contributes to persistence, Cell Microbiol., 15, 961, 10.1111/cmi.12089

Spooner, 2011, The role of reactive-oxygen-species in microbial persistence and inflammation, Int. J. Mol. Sci., 12, 334, 10.3390/ijms12010334

Inaba, 2014, Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation, Cell Microbiol., 16, 131, 10.1111/cmi.12211

Baqui, 1998, Granulocyte- macrophage colony-stimulating factor amplification of interleukin-1b and tumor necrosis factor alpha production in THP-1 human monocytic cells stimulated with lipopolysaccharide of oral microorganisms, Clin. Diagn. Lab. Immunol., 5, 341, 10.1128/CDLI.5.3.341-347.1998

Fischman, 2015, Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model, Oncotarget, 6, 22613, 10.18632/oncotarget.4209

Rubinstein, 2013, Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/b-catenin signaling via its FadA adhesin, Cell Host Microbe, 14, 195, 10.1016/j.chom.2013.07.012

Park, 2017, Intratumoral Fusobacterium nucleatum abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma, Virchows Arch., 471, 329, 10.1007/s00428-017-2171-6

Chen, 2017, Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade, Oncotarget, 8, 31802, 10.18632/oncotarget.15992

Wu, 2018, Fusobacterium nucleatum potentiates intestinal tumorigenesis in mice via a Toll-like receptor 4/p21-activated kinase 1 cascade, Dig. Dis. Sci., 63, 1210, 10.1007/s10620-018-4999-2

Uitto, 2005, Fusobacterium nucleatum increases collagenase 3 production and migration of epithelial cells, Infect. Immun., 73, 1171, 10.1128/IAI.73.2.1171-1179.2005

Landskron, 2014, Chronic inflammation and cytokines in the tumor microenvironment, J. Immunol. Res., 2014, 149185, 10.1155/2014/149185

Mittal, 2014, Reactive oxygen species in inflammation and tissue injury, Antioxid. Redox Signal., 20, 1126, 10.1089/ars.2012.5149

Sessa, 2012, Nitric oxide synthases: Regulation and function, Eur. Heart J., 33, 829, 10.1093/eurheartj/ehr304

Abranches, J., Zeng, L., Kajfasz, J.K., Palmer, S.R., Chakraborty, B., Wen, Z.T., Richards, V.P., Brady, L.J., and Lemos, J.A. (2018). Biology of oral streptococci. Microbiol. Spectr., 6.

Brauncajs, 2001, Production of hydrogen peroxide by lactobacilli colonising the human oral cavity, Med. Dośw. Mikrobiol., 53, 331

Hussain, 2003, Radical causes of cancer, Nat. Rev. Cancer, 3, 276, 10.1038/nrc1046

Piao, 2016, Helicobacter pylori activates IL-6-STAT3 signaling in human gastric cancer cells: Potential roles for reactive oxygen species, Helicobacter, 21, 405, 10.1111/hel.12298

Koczorowski, 2001, Halitosis—Problem społeczny. Halitosis—A social problem, Now. Lek., 70, 657

Koczorowski, 2004, Badanie zależności między halitosis a chorobami przyzębia. A study of the relationship between halitosis and periodontal diseases, Dent. Forum, 30, 51

Milella, 2015, The negative effects of volatile sulphur compounds, J. Vet. Dent., 32, 99, 10.1177/089875641503200203

Wagner, 2006, Evidence that hydrogen sulfide is a genotoxic agent, Mol. Cancer Res., 4, 9, 10.1158/1541-7786.MCR-05-0126

Hellmich, 2015, Hydrogen sulfide and cancer, Handb. Exp. Pharmacol., 230, 233, 10.1007/978-3-319-18144-8_12

Singh, 2015, Hydrogen sulfide in physiology and diseases of the digestive tract, Microorganisms, 3, 866, 10.3390/microorganisms3040866

Szkaradkiewicz, 2013, Characteristic of bacteriocines and their application, Pol. J. Microbiol., 62, 223, 10.33073/pjm-2013-030

Hooper, 2007, A molecular analysis of the bacteria present within oral squamous cell carcinoma, J. Med. Microbiol., 56, 1651, 10.1099/jmm.0.46918-0

Senneby, A., Davies, J.R., Svensäter, G., and Neilands, J. (2017). Acid tolerance properties of dental biofilms in vivo. BMC Microbiol., 17.

Downes, 2006, Peptostreptococcus stomatis sp. nov., isolated from the human oral cavity, Int. J. Syst. Evol. Microb., 56, 751, 10.1099/ijs.0.64041-0

Lunt, 2009, The tumor microenvironment and metastatic disease, Clin. Exp. Metastasis, 26, 19, 10.1007/s10585-008-9182-2

Mazzio, 2010, Evaluation of endogenous acidic metabolic products associated with carbohydrate metabolism in tumor cells, Cell Biol. Toxicol., 26, 177, 10.1007/s10565-009-9138-6

Pavlova, 2013, Multiple alcohol dehydrogenases but no functional acetaldehyde dehydrogenase causing excessive acetaldehyde production from ethanol by oral streptococci, Microbiology, 159Pt 7, 1437, 10.1099/mic.0.066258-0

Marttila, 2013, Fermentative 2-carbon metabolism produces carcinogenic levels of acetaldehyde in Candida albicans, Mol. Oral Microbiol., 28, 281, 10.1111/omi.12024

Salaspuro, 1997, Microbial metabolism of ethanol and acetaldehyde and clinical consequences, Addict. Biol., 2, 35, 10.1080/13556219772840

Meurman, 2008, Oral micro-organisms in the etiology of cancer, Acta Odontol. Scand., 66, 321, 10.1080/00016350802446527

Muto, 2000, Acetaldehyde production by non-pathogenic Neisseria in human oral microflora: Implications for carcinogenesis in upper aerodigestive tract, Int. J. Cancer, 88, 342, 10.1002/1097-0215(20001101)88:3<342::AID-IJC4>3.0.CO;2-I